NASDAQ:CNCE

Concert Pharmaceuticals Insider Trades

$4.01
0.00 (0.00 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.92
$4.14
50-Day Range
$3.87
$6.16
52-Week Range
$3.82
$13.50
Volume206,283 shs
Average Volume448,291 shs
Market Capitalization$129.02 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77

Insider Trades

Concert Pharmaceuticals (NASDAQ:CNCE) Insider Buying and Selling Activity

Insider Ownership Percentage: 10.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $285,625.14

Insider Buying and Selling by Quarter


Concert Pharmaceuticals (NASDAQ CNCE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/17/2021Roger D TungCEOSell13,480$7.20$97,056.00808,578  
2/16/2021Jeffrey A MunsieInsiderSell3,763$7.32$27,545.1646,153  
2/16/2021Nancy StuartCOOSell6,049$7.32$44,278.68173,280  
6/22/2020Nancy StuartCOOSell10,295$11.34$116,745.30167,924  
3/12/2020Thomas G AuchinclossDirectorBuy1,500$8.52$12,780.006,500  
2/3/2020Thomas G AuchinclossDirectorBuy1,000$10.91$10,910.005,000  
10/8/2019Heek Christi VanDirectorBuy5,000$5.90$29,500.005,000  
8/8/2019Peter Barton HuttDirectorSell3,539$10.31$36,487.097,963  
8/2/2019Heek Christi VanDirectorBuy5,000$10.84$54,200.005,000  
6/10/2019Bvf Partners L P/IlMajor ShareholderSell386,289$10.70$4,133,292.30  
11/15/2018Richard AldrichDirectorBuy50,000$11.83$591,500.00296,975  
7/10/2018Nancy StuartCOOSell31,418$17.87$561,439.66116,085  
4/17/2018James V CassellaInsiderSell10,582$20.18$213,544.7630,000  
2/1/2018Richard AldrichDirectorSell11,946$20.89$249,551.94286,975  
1/29/2018Richard AldrichDirectorSell18,054$20.63$372,454.02286,975  
1/26/2018Richard AldrichDirectorSell5,000$20.46$102,300.00286,975  
1/24/2018Richard AldrichDirectorSell30,000$19.68$590,400.00286,975  
1/22/2018Richard AldrichDirectorSell10,000$19.55$195,500.00286,975  
1/19/2018Richard AldrichDirectorSell30,000$19.35$580,500.00286,975  
1/16/2018Richard AldrichDirectorSell31,236$19.14$597,857.04286,975  
12/19/2017Value Fund L P BiotechnologyInsiderSell1,282,856$26.65$34,188,112.40  
12/4/2017Ronald W BarrettDirectorSell14,156$24.70$349,653.203,539  
10/19/2017Value Fund L P BiotechnologyInsiderBuy331,916$15.84$5,257,549.44  
9/14/2017Ryan LynchInsiderSell3,500$14.51$50,785.009,500  
5/12/2016Thomas G AuchinclossDirectorBuy2,000$10.11$20,220.002,000  
5/11/2016Roger D TungCEOBuy19,610$10.55$206,885.50538,965  
12/16/2015Wilfred E JaegerDirectorSell10,360$19.57$202,745.20  
12/15/2015Wilfred E JaegerDirectorSell54,572$20.10$1,096,897.20  
12/14/2015Pauline McgowanVPSell498$20.07$9,994.86  
12/14/2015Wilfred E JaegerDirectorSell3,922$20.09$78,792.98  
11/9/2015Ronald W. BarrettDirectorSell17,699$22.27$394,156.73  
11/2/2015Nancy StuartCOOSell23,216$24.29$563,916.6425,004  
9/18/2015Robert SilvermanVPSell10,000$20.00$200,000.0010,000  
9/10/2015Wilfred E JaegerDirectorSell120,000$18.22$2,186,400.00  
8/18/2015Wilfred E JaegerDirectorSell760,000$15.81$12,015,600.00  
8/13/2015Wilfred E JaegerDirectorSell92,215$16.75$1,544,601.25  
8/12/2015Wilfred E JaegerDirectorSell97,785$17.49$1,710,259.65  
6/8/2015Robert SilvermanVPSell5,000$16.35$81,750.00  
3/11/2015Nancy StuartCOOSell46,430$15.00$696,450.00  
3/11/2015Pauline McgowanVPSell5,973$16.00$95,568.00  
3/10/2015Pauline McgowanVPSell22,122$13.90$307,495.80  
11/18/2014Three Arch Management Iv, L.L.DirectorSell250,000$12.29$3,072,500.00  
2/20/2014Skyline Venture Partners QualiMajor ShareholderBuy150,000$14.00$2,100,000.00  
2/19/2014Life Science Ventures Vi G TvmDirectorBuy89,000$14.00$1,246,000.00  
2/19/2014Plc GlaxosmithklineMajor ShareholderBuy35,000$14.00$490,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.